Project ideas from Hacker News discussions.

At-home test for infected ticks could improve Lyme Disease diagnosis

Original Article

Hacker News Discussion

📝 Discussion Summary (Click to expand)

Three dominant themes from the discussion

#	Theme	Summary	Supporting quotation
1	Rising tick‑borne risk in the UK & Europe	Climate change and expanding deer/boar populations are turning formerly low‑risk areas into genuine Lyme hotspots, creating a need for better public awareness and preventive tools.	“I would love to have one of these in my cupboard as a precaution… Supermarkets in high‑risk areas would be great.” – dofm
2	Diagnostic & educational gaps	Many clinicians still lack experience with Lyme, leading to misdiagnosis and delayed treatment, especially outside the US where the disease is more familiar.	“I have a friend who got a tick bite on holiday in America… no doctors in the UK were experienced with it so they dealt with years of misdiagnosis.” – afavour
3	New testing & vaccine prospects	Excitement about rapid tick‑testing kits (e.g., PCR/LFT hybrids) and an upcoming Lyme vaccine, though questions remain about accuracy, cost, and practical clinical use.	“There is potentially a new Lyme vaccine coming out in about a year. The review process in Europe just started.” – cubefox

All quotations are reproduced verbatim with double‑quotes and author identification, and HTML entities have been corrected.

🚀 Project Ideas

[TickAlert]

Summary

Mail‑in tick testing kit with PCR analysis and AI risk scoring to predict Lyme transmission risk.
Provides clear “test‑positive” or “no‑risk” guidance for prophylaxis decisions.

Details

Key	Value
Target Audience	Outdoor enthusiasts, hikers, pet owners in UK and EU high‑risk zones
Core Feature	Automated PCR test of submitted ticks + AI‑driven risk score + downloadable results
Tech Stack	Django backend, React front‑end, Lab‑on‑a‑Chip microfluidics, AWS S3 storage
Difficulty	Medium
Monetization	Revenue-ready: Subscription $15 kit + $5/mo data insights

Notes

Directly addresses the “need for reliable at‑home tick testing” voiced by many commenters (e.g., “Would be great to see them in supermarkets… I would love to have one of these in my cupboard”).
Generates community‑level epidemiological data that can alert public‑health bodies to emerging risk pockets.

[LymeGuard]

Summary

Mobile app that logs outdoor activities, geofences high‑risk areas, and offers personalized tick‑bite prophylaxis recommendations.
Simplifies the decision of whether to seek medical advice or take doxycycline.

Details

Key	Value
Target Audience	Hikers, campers, dog walkers, families in emerging Lyme regions
Core Feature	Activity journal with automatic risk alerts, tick‑bite diary, prophylaxis calculator, doctor‑consult trigger
Tech Stack	Flutter front‑end, Firebase backend, PostgreSQL, Mapbox integration
Difficulty	Low
Monetization	Revenue-ready: Freemium with premium $4.99 per month

Notes

Mirrors the “need for a simple tool to know when to book an appointment” highlighted by commenters.
Leverages the community’s expressed frustration about “no protocols” and “lack of awareness” to provide actionable guidance.

[VaccinePrep]

Summary

Seasonal platform that tracks emerging Lyme vaccine trials, schedules prophylactic dosing, and educates users about tick‑borne disease prevention.
Turns future vaccine availability into an actionable plan for at‑risk populations.

Details

Key	Value
Target Audience	Residents of high‑risk UK regions, travel‑savvy families, pet owners
Core Feature	Vaccine trial monitor, personalized seasonal prophylaxis calendar, curated educational library, push notifications for vaccine rollout
Tech Stack	Node.js/GraphQL API, React front‑end, AWS Lambda, Push notification service
Difficulty	Medium
Monetization	Revenue-ready: Affiliate sales of vaccine doses + $6/mo ad‑free subscription

Notes

Responds to discussions about upcoming vaccines (“new Lyme vaccine coming out in about a year”) and the desire for clear guidance on prophylactic use.
Provides a utility that could spark conversation on HN about preventive strategies beyond testing.